Stay updated on NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial
Sign up to get notified when there's something new on the NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial page.

Latest updates to the NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe revision history now shows a new entry for v3.6.3, replacing the previous v3.6.2. This indicates a minor update to the page’s revision metadata.SummaryDifference0.1%

- Check15 days agoChange DetectedA new revision entry (v3.6.2) has been added to the study history, showing a software version update to the record-keeping interface.SummaryDifference0.1%

- Check30 days agoChange DetectedEnrollment is updated to no longer looking for participants, signaling that recruitment has ended. The revision history now shows a new tag v3.6.0, replacing the previous v3.5.5 tag.SummaryDifference0.4%

- Check37 days agoChange DetectedThe footer now shows Revision: v3.5.5 instead of Revision: v3.5.4, indicating a newer site version was deployed.SummaryDifference0.1%

- Check58 days agoChange DetectedThe record history now shows a new release entry Revision: v3.5.4, replacing Revision: v3.5.3. This reflects a minor site update to ClinicalTrials.gov rather than changes to trial data.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page footer’s revision/version indicator was updated from 3.5.2 to 3.5.3 for the ClinicalTrials.gov site interface.SummaryDifference0.1%

Stay in the know with updates to NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial page.